An interventional study of Virtual reality guided motor rehabilitation in Stroke Acute, sponsored by Nova Scotia Health Authority. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-18.
Sponsored by Nova Scotia Health Authority · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Stroke by Nova Scotia Health Authority — 5 open to participants now, 5 under way, none of them phase 3. Stroke · Nova Scotia Health Authority.
Among the 14 studies in Stroke by Nova Scotia Health Authority, this one is the 2nd largest by planned enrollment of the 11 interventional ones that give a count, is one of 3 that started in 2025, is one of 10 with no phase, and was the 13th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →5 of the 14 studies in Stroke by Nova Scotia Health Authority are open now, in 1 country. Recruiting first, the newest first:
Nova Scotia Health Authority · Sites in Canada
Ages 18+
Nova Scotia Health Authority · Sites in Canada
Ages 18+
Nova Scotia Health Authority · Sites in Canada
Nova Scotia Health Authority · Sites in Canada
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 3 started in 2025.
This study's planned enrollment of 40 is below the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 14 across the 11 interventional studies, 62 across the 3 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Nova Scotia Health Authority is the lead sponsor of 264 studies on the registry; 77 are open to participants now.
4 of the studies in Stroke by Nova Scotia Health Authority that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05595668Nova Scotia Health AuthorityEngaging Mobile Prism Adaptation Treatment at Home | 2026-11 |
| NCT06864741Nova Scotia Health AuthorityVirtual Reality Rehabilitation for Stroke Patients in the Hospital and at Home. | 2027-06 |
| NCT06495450Nova Scotia Health AuthorityUsing Omnidirectional Virtual Reality and Treadmill Training for Chronic Stroke | 2027-08-06 |
| NCT07143162Nova Scotia Health AuthorityYOGA-FIT: Protocol for a Crossover Trial Investigating the Feasibility and Impact of Yoga for People With Stroke | 2027-10-10 |
Add all 4 to your calendar (.ics) → With an account.
Among the 14 studies in Stroke by Nova Scotia Health Authority, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to test whether a low-cost virtual reality (VR) motor rehabilitation platform can improve motor recovery in people recovering from a first-time ischemic stroke both in the hospital and at home. The study focuses on adults aged 18 and older who have experienced moderate to severe upper limb motor deficits.
The main questions it aims to answer are:
Researchers will compare patients receiving VR therapy to those receiving standard care to see if the VR therapy leads to greater improvements in motor recovery and more positive patient experiences.
Participants will:
This study will help determine whether VR-based rehabilitation can be a practical, effective way to improve access to therapy and recovery outcomes for stroke patients, especially in rural settings with limited rehabilitation resources.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Inpatient standard of care for acute stroke
Inpatient supplementary rehabilitation delivered through a virtual reality headset
Behavioral: Virtual reality guided motor rehabilitation
Outpatient standard of care for acute stroke
Outpatient supplementary rehabilitation delivered through a virtual reality headset
Behavioral: Virtual reality guided motor rehabilitation
Custom rehabilitation exercises running on a Meta Quest 2/3S/3 head mounted virtual reality display.
Treatment effectiveness in hospital
Measure if patients receiving supplementary VR motor therapy show improved motor recovery compared to receiving standard care in hospital using the Fugl-Meyer Assessment's Upper Limb Extremity Subscore. Values range from 0 to 66 with lower scores indicating a larger motor deficit.
Time frame: From enrollment to one week following the end of treatment at day 26
Treatment effectiveness at home
Measure if patients receiving supplementary VR motor therapy show improved motor recovery compared to receiving standard care for home-based patients using the Fugl-Meyer Assessment's Upper Limb Extremity Subscore. Values range from 0 to 100 with lower scores indicating a larger motor deficit.
Time frame: From enrollment through standard of care and VR treatment completion on Day 47
Treatment feasibility - Motion Sickness
Measure motion sickness levels immediately after each therapy sessions using the Virtual Reality Sickness Questionnaire. Values range from 0 to 100 with higher scores indicating more reported motion sickness.
Time frame: From enrollment to one week following the end of treatment
Treatment feasibility - Attitudes towards technology
Measure attitudes towards the VR technology before and after the intervention using a VR Attitudes Survey. Values range from 0 to 6 with higher scores indicating more favorable attitudes towards the VR technology.
Time frame: From enrollment to one week following the end of treatment
Patient engagement at home
Assess patient engagement with adaptive at-home rehabilitation using the percentage of daily sessions completed. Values range from 0% to 100% with higher scores indicating a higher rate of session completion.
Time frame: From enrollment through standard of care and VR treatment completion on Day 47
Treatment effectiveness - Motor performance
Measure if patients receiving VR motor therapy show improved motor performance using the Box and Blocks Test. Values range from 0 to 150 with higher scores indicating improved motor performance.
Time frame: From enrollment to one week following the end of treatment
Treatment effectiveness - Quality of life
Measure if patients receiving VR motor therapy show reduced disability and improved health-related quality of life using the Stroke Impact Scale. Values range from 0 to 100 with higher scores indicating reduced disability and higher quality of life.
Time frame: From enrollment to one week following the end of treatment
VR motor assessment validity
Examine the validity of a VR motor assessment for monitoring stroke motor recovery trajectories in the real world. This will be explored by comparing data between the real-world and virtual Box and Blocks tests which will result in a correlation coefficient ranging from 0 to 1 with a higher value indicating a stronger alignment in metrics.
Time frame: From enrollment to one week following the end of treatment
Gender differences in acceptance of VR rehabilitation technology
Analyze differences between women and men in relation to the acceptance of VR treatment, using the VR Attitudes Survey. Values range from 0 to 6 with higher scores indicating more favorable attitudes towards the VR technology.
Time frame: From enrollment to one week following the end of treatment
Independent use of home-based VR treatment
By meeting certain criteria during the study, participants can qualify to complete VR sessions on their own. Measure the proportion of participants qualifying for independent operation.
Time frame: From enrollment through standard of care and VR treatment completion on Day 47
Performance characteristics of stroke patients
Measure motor performance for each task over time using motor performance z-scores. Mean scores equal zero with deviations indicating distance in standard deviations from the mean (with no minimum or maximum). Higher scores indicate better motor performance.
Time frame: From enrollment to last VR rehabilitation session
Barriers to treatment adoption
Qualitative feedback will be analyzed thematically to identify potential barriers and enablers of adopting VR stroke rehabilitation. This qualitative analysis does not use a quantitative scale.
Time frame: From enrollment to one week following the last VR session
Plan to share: Undecided — Given the small sample size and single recruitment site, the investigators are uncertain if confidentiality can be ensured with sharing IPD. The investigators will address this with the institution's Research Ethics Board.
No publications or documents are linked to this record.
Started Oct 2025 (actual). Primary completion is estimated for Jun 2027, 20 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 20 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nova Scotia Health Authority →